U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
Fabian Benz(RWTH Aachen University), Tom Luedde(Medizinische Hochschule Hannover), Norbert Frey(University Hospital Schleswig-Holstein), Lukas Nieuwenhuijsen(RWTH Aachen University), David Vargas Cardenas(RWTH Aachen University), Jérémie Gautheron(RWTH Aachen University), Alexander Koch(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Medizinische Hochschule Hannover), Christoph Roderburg(Universitätsklinikum Aachen), Henning W. Zimmermann(RWTH Aachen University), Mark Luedde(Christian-Albrechts-Universität zu Kiel), Jörn Janssen(RWTH Aachen University), Christian Trautwein(Medizinische Hochschule Hannover)
Cited by 172
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786